Serum transforming growth factor-β1 is related to the degree of immunoparesis in patients with multiple myeloma

Medical Oncology

Volumn 15, Issue 2, 1998, Pages 124-128

  Kyrtsonis, Maria Christina ^a   Repa, Constantina ^a   Dedoussis, George V Z ^b   Mouzaki, Athanasia ^a   Simeonidis, Argyris ^c   Stamatelou, Marina ^a   Maniatis, Alice ^a,d  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b Hellenic Anticancer Institute   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

^d UNIVERSITY OF PATRAS   (Greece)

Author keywords

Immunoparesis; Multiple myeloma; Transforming growth factor 1

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOLOGY; MULTIPLE MYELOMA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0031683388     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02989591     Document Type: Article

References (21)

1. Laurence DA. Transforming growth factorβ. In: Cavaillon JM (ed). Les Cytokines. Masson: Paris, 1993; 273-284.
2. Lotz M, Ranheim E, Kipps TJ. Transforming growth factorβ as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med 1994; 179: 999-1004.
3. Derynck R et al. Synthesis of messenger RNAs for transforming growth factor α and β and the epidermal growth factor receptor by human tumors. Cancer Res 1987; 47: 707-712.
4. Fava RA et al. Synthesis of transforming growth factor β1 by megakaryocyte and its localisation to megakaryocyte and platelet α-granules. Blood 1990; 76: 1946-1955.
5. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor β (TGFβ). Growth factors 1993; 8: 1-9.
6. Berg DJ, Lynch RG. Immune dysfunction in mice with plasmacytomas. J Immunol 1991; 146: 2865-2872.
7. Johnson BH, Gomi M, Jakowlew SB, Moriwaki K, Thompson EB. Actions and interactions of glucocorticoids and TGFβ on two related human myeloma cell lines. Cell Growth Differ 1993; 4: 25-30.
8. Jiang X, Kanai H, Hiromura K, Sawamura M, Yano S. Increased intraplatelet and urinary transforming growth factor β in patients with multiple myeloma. Acta Haematol 1995; 94: 1-6.
9. Gheraldi RK et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 1996; 87: 1458-1465.
10. Urashima M et al. Transforming growth factor β1: Differential effects on multiple myeloma versus normal B cells. Blood 1996; 87: 1928-1938.
11. Cavo M et al. Prognostic variables and clinical staging in multiple myeloma. Blood 1989; 74: 1774-1780.
12. Zeidler C et al. In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates. Blood 1972; 80: 2740-2748.
13. Klein B. Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma. Semin Hematol 1995; 32: 4-19.
14. Herrmann F et al. Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression. Blood 1991; 78: 2070-2074.
15. Kyrtsonis M-C, Dedoussis G, Baxevanis C, Stamatelou M, Maniatis A. Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM). Br J Haematol 1996; 92: 420-422.
16. Klein B, Zhang X-G, Lu Z-Y, Bataille R. Interleukin-6 in human multiple myeloma. Blood 1995; 85: 863-872.
17. Munshi NC. Immunoregulatory mechanisms in multiple myeloma. Hemat Oncol Clin NA 1997; 11: 51-69.
18. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J. Growth inhibition by TGFβ linked to suppression of retinoblastoma protein phosphorylation. Cell 1990; 62: 175-185.
19. Lagneaux L et al. Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukemia: correlation with the expression of TGFβ receptors. Br J Haematol 1997; 97: 612-620.
20. Dao DD et al. Deletion of the retinoblastoma gene in multiple myeloma. Leukemia 1994; 8: 1280-1284.
21. Markowitz SD, Roberts AB. Tumor suppressor activity of TGFβ pathway in human cancers. Cytokine Growth Factor Rev 1996; 7: 93-102.